{
  "timestamp": "20250104_032015",
  "model": "gpt-4-turbo",
  "interaction_type": "enhancement_with_chain_without_enhancer",
  "question_id": "602a9994",
  "question_text": "Propronolol is useful in all except -",
  "messages": [
    {
      "role": "system",
      "content": "You are a medical expert making decisions based on enhanced information and careful verification."
    },
    {
      "role": "user",
      "content": "You are a medical expert specializing in Pharmacology.\n        Your task:\n        - You have per-option reasoning chains (from previous step).\n        - You have retrieved evidence paths (enhanced graph info) that are correct but may be broad and not directly addressing the key point.\n        - Use standard medical/biochemical consensus to evaluate each chain.\n        - If a chain step contradicts consensus, correct or remove it.\n        - Check evidence paths: if they provide relevant support or clarify consensus, incorporate them.\n        - If paths are too broad or not relevant, do not let them mislead you.\n        - Aim to produce a final \"enhanced_information\" that:\n          1. Reflects corrected, consensus-aligned reasoning for each option,\n          2. Integrates helpful evidence from paths,\n          3. Excludes misleading or irrelevant info,\n          4. Focuses on what best helps answer the question correctly.\n\n        ### Question\n        Propronolol is useful in all except -\n\n        ### Options\n        opa. Atrial flutter\nopb. Parkinsonian tremor\nopc. Thyrotoxicosis\nopd. HOCM\n\n### Reasoning Chains per Option:\nCHAIN: \"Propranolol\" -> \"non-selective beta-blocker\" -> \"reduces sympathetic nervous system activity\" -> \"decreases heart rate and contractility\" -> \"useful in atrial flutter\" -> 95%\nCHAIN: \"Propranolol\" -> \"non-selective beta-blocker\" -> \"reduces sympathetic nervous system activity\" -> \"decreases tremors\" -> \"useful in Parkinsonian tremor\" -> 80%\nCHAIN: \"Propranolol\" -> \"non-selective beta-blocker\" -> \"blocks beta receptors\" -> \"reduces symptoms of thyrotoxicosis\" -> \"useful in thyrotoxicosis\" -> 90%\nCHAIN: \"Propranolol\" -> \"non-selective beta-blocker\" -> \"decreases heart rate and contractility\" -> \"may worsen outflow obstruction\" -> \"not useful in HOCM\" -> 85%\n\n### Retrieved Evidence Paths (broad but correct):\n(Tremor)-CAUSES->(Parkinsonian tremor)\n(Propranolol)-ISA->(Pharmaceutical Preparations)-INTERACTS_WITH->(Adrenergic beta-Antagonists)\n(Propranolol)-INTERACTS_WITH->(Pharmaceutical Preparations)-INTERACTS_WITH->(Adrenergic beta-Antagonists)\n(Propranolol)-ISA->(Pharmaceutical Preparations)-INTERACTS_WITH->(Adrenergic beta-Antagonists)\n(Propranolol)-INTERACTS_WITH->(Pharmaceutical Preparations)-INTERACTS_WITH->(Adrenergic beta-Antagonists)\n(Propranolol)-ISA->(Pharmaceutical Preparations)-INTERACTS_WITH->(Adrenergic beta-Antagonists)\n(Propranolol)-INTERACTS_WITH->(Pharmaceutical Preparations)-INTERACTS_WITH->(Adrenergic beta-Antagonists)\n(Propranolol)-ISA->(Pharmaceutical Preparations)-INTERACTS_WITH->(Adrenergic beta-Antagonists)\n(Propranolol)-INTERACTS_WITH->(Pharmaceutical Preparations)-INTERACTS_WITH->(Adrenergic beta-Antagonists)\n\n        ### Instructions:\n        1. Recall standard consensus facts relevant to the question.\n        2. For each option's chain, compare steps to consensus and paths:\n           - Remove/adjust steps contradicting known facts.\n           - If paths confirm or clarify a point aligned with consensus, use them.\n           - Ignore irrelevant or overly broad paths that don't help.\n        3. If uncertain, note uncertainty but choose the best consensus-supported interpretation.\n        4. Output a short \"enhanced_information\" summarizing the corrected reasoning and relevant evidence that truly aids in final answer determination.\n\n        ### Output Format:\n        {\n          \"enhanced_information\": \"A concise, consensus-aligned summary integrating corrected reasoning and relevant evidence.\"\n        }\n        "
    }
  ],
  "response": "### Enhanced Information Summary\n\nPropranolol, a non-selective beta-blocker, is known to reduce sympathetic nervous system activity, which affects heart rate and contractility. This makes it useful in conditions where a reduction in heart rate and contractility is beneficial.\n\n1. **Atrial Flutter**: Propranolol is effective in managing atrial flutter because it decreases heart rate, which can help in controlling this arrhythmia. This aligns with the standard medical consensus that beta-blockers are useful in managing various types of cardiac arrhythmias including atrial flutter.\n\n2. **Parkinsonian Tremor**: Although propranolol is a beta-blocker that can reduce tremors, its primary use in tremor management is for essential tremor rather than Parkinsonian tremor. Parkinsonian tremor is typically managed with dopaminergic drugs, and the use of propranolol is not a first-line treatment or widely recognized as effective for Parkinsonian tremors. This contradicts the initial reasoning chain and aligns with the consensus that propranolol is not typically useful for Parkinsonian tremor.\n\n3. **Thyrotoxicosis**: Propranolol is beneficial in managing symptoms of thyrotoxicosis, such as tachycardia and anxiety, by blocking beta receptors. This is a well-established use of propranolol in medical practice.\n\n4. **Hypertrophic Obstructive Cardiomyopathy (HOCM)**: In the case of HOCM, while propranolol reduces heart rate and contractility, it may worsen the condition by increasing outflow tract obstruction due to its negative inotropic effects (reduced force of heart muscle contraction). This is consistent with medical guidelines that advise caution or avoidance of beta-blockers like propranolol in HOCM unless specifically indicated under controlled conditions.\n\nThe retrieved evidence paths primarily confirm propranolol's classification and interactions as a beta-blocker but do not provide additional specific insights into the conditions discussed. Therefore, they support the classification of propranolol but do not alter the conclusions drawn from the medical consensus.\n\n**Conclusion**: Based on the corrected reasoning and medical consensus, propranolol is useful in atrial flutter and thyrotoxicosis but not in Parkinsonian tremor and may be contraindicated in HOCM, making Parkinsonian tremor and HOCM the exceptions where propranolol is not typically useful.\n\n```json\n{\n  \"enhanced_information\": \"Propranolol is effective in managing atrial flutter and thyrotoxicosis by reducing heart rate and blocking beta receptors, respectively. However, it is not typically useful for Parkinsonian tremor, where dopaminergic drugs are preferred, and may worsen conditions like Hypertrophic Obstructive Cardiomyopathy (HOCM) due to its negative inotropic effects.\"\n}\n```",
  "metadata": {
    "topic": "Pharmacology",
    "is_multi_choice": true,
    "has_reasoning_chain": true,
    "has_enhanced_info": false,
    "model_config": "gpt-4-turbo",
    "temperature": 0.0
  }
}